Initially there was no specific way to reverse the anticoagulant anticoagulant you know I mean you know so I mean well um anticoagulant anticoagulant anticoagulant anticoagulant anticoagulant anticoagulant effect of dabigatran in um well um um so I mean I mean the event of a a a a a a um uh you know okay you know I mean you know a a major bleeding event, unlike for warfarin, but a dabigatran antidote (idarucizumab) was approved by the FDA in 2015.